Matthew E Korenberg Ligand Pharmaceuticals Inc (LGND) insider trading activity

Matthew E Korenberg is President & COO of LIGAND PHARMACEUTICALS INC. Currently has a direct ownership of 50,777 shares of LGND, which is worth approximately $5.95 Million. The most recent transaction as insider was on Jun 10, 2022, when has been sold 8,062 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 50.8K

0% 3M change

46.11% 12M change

Total Value Held $5.95 Million

Matthew E Korenberg Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jun 10 2022	BUY Grant, award, or other acquisition	-	8,062 Added 13.34%	52,368 Common Stock
Feb 15 2022	SELL Payment of exercise price or tax liability	$421,378 $123.68 p/Share	3,407 Reduced 7.14%	44,306 Common Stock
Jan 26 2022	SELL Payment of exercise price or tax liability	$412,431 $113.68 p/Share	3,628 Reduced 7.07%	47,713 Common Stock
Jan 26 2022	BUY Grant, award, or other acquisition	-	11,651 Added 18.5%	51,341 Common Stock
Jun 30 2021	BUY Other acquisition or disposition	$21,220 $85.91 p/Share	247 Added 0.62%	39,690 Common Stock
Feb 15 2021	SELL Payment of exercise price or tax liability	$398,210 $172.46 p/Share	2,309 Reduced 5.53%	39,443 Common Stock
Feb 03 2021	BUY Grant, award, or other acquisition	-	10,819 Added 20.58%	41,752 Common Stock
Jan 25 2021	SELL Payment of exercise price or tax liability	$329,337 $156.01 p/Share	2,111 Reduced 6.39%	30,933 Common Stock
Jan 25 2021	BUY Grant, award, or other acquisition	-	7,108 Added 18.0%	32,373 Common Stock

Also insider at

QLGN

Qualigen Therapeutics, Inc. Healthcare

Director

LNDC

LANDEC CORP \CA\ Healthcare

Director

PIRS

PIERIS PHARMACEUTICALS, INC. Healthcare

CFO, Treasurer

MEK